Suzu Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 3 Year, 7 Months
About Suzu Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Niaz Ahmed and Manjuara Ahmed serve as directors at the Company.
- CIN/LLPIN
U33110AS2021PTC021452
- Company No.
021452
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jun 2021
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Darrang, Assam, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Suzu Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Niaz Ahmed  | Director | 09-Jun-2021 | Current |
| Manjuara Ahmed | Director | 09-Jun-2021 | Current |
Financial Performance of Suzu Pharmaceuticals.
Enhance accessibility to Suzu Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Suzu Pharmaceuticals?
Unlock access to Suzu Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Suzu Appliances Private LimitedActive 3 years 6 monthsNiaz Ahmed and Manjuara Ahmed are mutual person
- Suzu Electricals Private LimitedActive 4 years 1 month
Niaz Ahmed and Manjuara Ahmed are mutual person
- Suzu Multi Trades Private LimitedActive 3 years 7 months
Niaz Ahmed and Manjuara Ahmed are mutual person
- Suzu Hardwares Private LimitedActive 3 years 6 months
Niaz Ahmed and Manjuara Ahmed are mutual person
- Suzu Food Industries Private LimitedActive 6 years 6 months
Niaz Ahmed and Manjuara Ahmed are mutual person
- Suzu Infra Projects Private LimitedActive 3 years 5 months
Niaz Ahmed and Manjuara Ahmed are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Suzu Pharmaceuticals?
Suzu Pharmaceuticals has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Suzu Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suzu Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.